Streptokinase biosimilar (Neiss)

链激酶生物类似药 (Neiss)

Report date: 2022/03/04 16:16:52

Base Information

Drug NameStreptokinase biosimilar (Neiss)

Drug Alias Name链激酶生物仿制药 (Neiss)Niskinase

ClassificationBiologics > BiosimilarBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme

Mechanisms of ActionPlasminogen activators

TargetsPlasminogen

Therapy Area/IndicationsMyocardial Infarction

Global Approved IndicationsMyocardial Infarction

Approved Indications in ChinaN/A

Original Approved Country/TerritoryIndia

Original Approved Date2012/01/01

Country/TerritoryIndia

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesNeiss Labs

China Registration ClassN/A

Develop Information

Active CompaniesNeiss Labs

Inactive CompaniesN/A

Active IndicationsMyocardial Infarction

Inactive IndicationsN/A

Other Information

ATC CodeB01AD01